JP3197938B2 - Cosmetic for preventing skin aging - Google Patents
Cosmetic for preventing skin agingInfo
- Publication number
- JP3197938B2 JP3197938B2 JP10913792A JP10913792A JP3197938B2 JP 3197938 B2 JP3197938 B2 JP 3197938B2 JP 10913792 A JP10913792 A JP 10913792A JP 10913792 A JP10913792 A JP 10913792A JP 3197938 B2 JP3197938 B2 JP 3197938B2
- Authority
- JP
- Japan
- Prior art keywords
- dha
- skin
- cosmetic
- epa
- components
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002537 cosmetic Substances 0.000 title claims description 20
- 230000009759 skin aging Effects 0.000 title claims description 13
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims description 31
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims description 29
- 239000003921 oil Substances 0.000 claims description 24
- 235000019198 oils Nutrition 0.000 claims description 24
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims description 23
- 239000003925 fat Substances 0.000 claims description 13
- 235000019197 fats Nutrition 0.000 claims description 13
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 12
- 239000000284 extract Substances 0.000 claims description 9
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims description 7
- 241000723346 Cinnamomum camphora Species 0.000 claims description 7
- 235000002566 Capsicum Nutrition 0.000 claims description 6
- VQAWRQZAAIQXHM-UHFFFAOYSA-N Cepharanthine Natural products O1C(C=C2)=CC=C2CC(C=23)N(C)CCC3=CC=3OCOC=3C=2OC(=CC=23)C(OC)=CC=2CCN(C)C3CC2=CC=C(O)C1=C2 VQAWRQZAAIQXHM-UHFFFAOYSA-N 0.000 claims description 6
- 239000006000 Garlic extract Substances 0.000 claims description 6
- 239000006002 Pepper Substances 0.000 claims description 6
- 235000016761 Piper aduncum Nutrition 0.000 claims description 6
- 235000017804 Piper guineense Nutrition 0.000 claims description 6
- 235000008184 Piper nigrum Nutrition 0.000 claims description 6
- 229960000846 camphor Drugs 0.000 claims description 6
- 229930008380 camphor Natural products 0.000 claims description 6
- YVPXVXANRNDGTA-WDYNHAJCSA-N cepharanthine Chemical compound C1C(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2C[C@H](C2=C3)N(C)CCC2=CC(OC)=C3OC2=C(OCO3)C3=CC3=C2[C@H]1N(C)CC3 YVPXVXANRNDGTA-WDYNHAJCSA-N 0.000 claims description 6
- 235000020706 garlic extract Nutrition 0.000 claims description 6
- 235000001968 nicotinic acid Nutrition 0.000 claims description 5
- 239000011664 nicotinic acid Substances 0.000 claims description 5
- 229960003512 nicotinic acid Drugs 0.000 claims description 5
- 229940098465 tincture Drugs 0.000 claims description 5
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims description 2
- 229940090949 docosahexaenoic acid Drugs 0.000 claims description 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims description 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims description 2
- 244000203593 Piper nigrum Species 0.000 claims 1
- 230000000694 effects Effects 0.000 description 23
- 239000006071 cream Substances 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- 206010013786 Dry skin Diseases 0.000 description 8
- 238000010438 heat treatment Methods 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 238000000034 method Methods 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 6
- 241000722363 Piper Species 0.000 description 5
- 235000019441 ethanol Nutrition 0.000 description 5
- -1 packs Substances 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 235000021323 fish oil Nutrition 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 240000002234 Allium sativum Species 0.000 description 3
- 241001149724 Cololabis adocetus Species 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 241001125048 Sardina Species 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 235000014593 oils and fats Nutrition 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 235000019512 sardine Nutrition 0.000 description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 241000269821 Scombridae Species 0.000 description 2
- 206010040844 Skin exfoliation Diseases 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 235000004611 garlic Nutrition 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 235000020640 mackerel Nutrition 0.000 description 2
- YNBADRVTZLEFNH-UHFFFAOYSA-N methyl nicotinate Chemical compound COC(=O)C1=CC=CN=C1 YNBADRVTZLEFNH-UHFFFAOYSA-N 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- GVJHHUAWPYXKBD-QLVXXPONSA-N (S,R,R)-alpha-tocopherol Chemical compound [H][C@@](C)(CCCC(C)C)CCC[C@@]([H])(C)CCC[C@@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2C GVJHHUAWPYXKBD-QLVXXPONSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 241001124076 Aphididae Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000002567 Capsicum annuum Nutrition 0.000 description 1
- 235000002568 Capsicum frutescens Nutrition 0.000 description 1
- 241000744472 Cinna Species 0.000 description 1
- 241000252203 Clupea harengus Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 241001071804 Gentianaceae Species 0.000 description 1
- 241000208680 Hamamelis mollis Species 0.000 description 1
- 241000026407 Haya Species 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 241000218195 Lauraceae Species 0.000 description 1
- 244000211187 Lepidium sativum Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- 241000967294 Swertia japonica Species 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000021336 beef liver Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229940025250 camphora Drugs 0.000 description 1
- 239000010238 camphora Substances 0.000 description 1
- 239000001511 capsicum annuum Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 229940013317 fish oils Drugs 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 235000019514 herring Nutrition 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229960001238 methylnicotinate Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000000199 molecular distillation Methods 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 230000001457 vasomotor Effects 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229940118846 witch hazel Drugs 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
【0001】[0001]
【産業上の利用分野】本発明は、化粧料に関し、更に詳
細には、優れた皮膚老化防止作用、肌荒れ改善作用等を
有する皮膚老化防止用化粧料に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a cosmetic, and more particularly, to a cosmetic for preventing skin aging which has an excellent skin aging preventive action, skin roughness improving action and the like.
【0002】[0002]
【従来の技術】従来、肌荒れ改善や皮膚老化防止のため
に用いられてきた薬効成分としては、アラントイン、ア
ロエ抽出物、人参抽出物、胎盤抽出物、牛血液除蛋白物
および発酵代謝物等が知られている。しかしながら、こ
れらの薬効成分を含む化粧料では、十分な効果を得るこ
とができず、より優れた作用を有する化粧料の開発が望
まれていた。2. Description of the Related Art Pharmaceutical ingredients conventionally used for improving skin roughness and preventing skin aging include allantoin, aloe extract, ginseng extract, placenta extract, bovine blood deproteinizing substances, and fermentation metabolites. Are known. However, cosmetics containing these medicinal components cannot provide a sufficient effect, and there has been a demand for the development of cosmetics having more excellent effects.
【0003】一方、抗炎症作用、抗アレルギー作用
(「油化学」,37, p9, (1988)、「油化学」,40,
p203, (1991))等を有する化合物として、エイコサ
ペンタエン酸(以下、「EPA」と略称する)及びドコ
サヘキサエン酸(以下、「DHA」と略称する)を含有
する油脂が注目されている。 このEPAやDHAは魚
油中に多く含まれており、血栓防止活性や、動脈硬化防
止活性などの薬理効果を有することが古くから知られて
いた。 また、近年では、局所投与した場合、血管運動
および血管拡張効果があることが見出された(特開平2
−48528号)。On the other hand, anti-inflammatory and anti-allergic effects ("Oil Chemistry", 37, p9, (1988), "Oil Chemistry", 40,
Oils and fats containing eicosapentaenoic acid (hereinafter abbreviated as "EPA") and docosahexaenoic acid (hereinafter abbreviated as "DHA") have attracted attention as compounds having p203, (1991)) and the like. It has long been known that EPA and DHA are contained in fish oil in a large amount and have pharmacological effects such as antithrombotic activity and antiarteriosclerosis activity. In recent years, it has been found that local administration has a vasomotor and vasodilator effect (Japanese Patent Laid-Open No.
-48528).
【0004】[0004]
【発明が解決しようとする課題】本発明者らは、EPA
やDHAの有する上記作用に着目し、これを化粧料、特
に皮膚老化防止を目的とする化粧料に配合することを試
みた。 しかし、EPAやDHAもしくはこれを含有す
る油脂類を単独に配合した場合の皮膚老化防止効果や肌
荒れ改善効果は十分なものとはいえず、また他の基剤等
の影響により、これらの本来有する効果が十分に発揮さ
れ得ないのが実情であった。SUMMARY OF THE INVENTION The present inventors have developed an EPA
Focusing on the above-mentioned effects of DHA and DHA, an attempt was made to blend this into cosmetics, especially cosmetics intended to prevent skin aging. However, when EPA, DHA or fats and oils containing EPA or DHA alone are blended alone, the effect of preventing skin aging and the effect of improving skin roughness are not sufficient, and due to the influence of other bases and the like, these substances originally have these effects. It was a fact that the effect could not be fully exerted.
【0005】さらに、より高い効果を得る目的でEPA
及び/またはDHAもしくはこれを含有する油脂類を高
濃度で配合した場合の作用効果にも限界があり、逆に、
これら化合物自体の有する特有の色や臭いの発生により
配合量や剤型等製品面における制限も生じてくるといっ
た問題もあった。[0005] Furthermore, in order to obtain higher effects, EPA
And / or DHA or fats and oils containing it at a high concentration has a limited effect, and conversely,
There is also a problem in that the production of specific colors and odors of these compounds themselves causes limitations in the product aspect such as the compounding amount and dosage form.
【0006】[0006]
【課題を解決するための手段】前記実情に鑑み、本発明
者等は、EPA及び/またはDHAもしくはこれを含有
する油脂類の有する作用を十分に引き出すべく鋭意研究
を行った。 そしてその結果、これらと特定の成分とを
組合せることにより、優れた皮膚老化防止効果、肌荒れ
改善効果が安定且つ相乗的に発揮されることを見出し本
発明を完成した。Means for Solving the Problems In view of the above-mentioned circumstances, the present inventors have conducted intensive studies in order to fully exploit the effects of EPA and / or DHA or fats and oils containing the same. As a result, it has been found that the combination of these and specific components exerts an excellent effect of preventing skin aging and improving skin roughness in a stable and synergistic manner, and completed the present invention.
【0007】すなわち本発明は、EPA及び/またはD
HAもしくはこれを含有する油脂類と、センブリエキ
ス、カンファ、ニコチン酸もしくはその誘導体、ニンニ
クエキス、セファランチンおよびトウガラシチンキから
選ばれる成分の一種または二種以上とを含有する皮膚老
化防止用化粧料を提供するものである。That is, the present invention relates to EPA and / or D
Provided is a cosmetic for preventing skin aging, comprising HA or an oil or fat containing the same, and one or more components selected from assembly extract, camphor, nicotinic acid or a derivative thereof, garlic extract, cepharanthin and pepper tincture. Is what you do.
【0008】EPA及び/またはDHAは、前記したよ
うに魚油、例えば、イワシ油、サンマ油、ニシン油、サ
バ油、タラ油等の中に多く含まれる不飽和脂肪酸であ
る。例えば、イワシ油はEPAを約16%、DHAを約
8.4%、サンマ油はEPAを約4.9%、DHAを約1
0.5%、サバ油はEPAを約8.1%、DHAを約1
0.6%、タラ油はEPAを約13.3%、DHAを約1
3.7%それぞれ含んでいる。[0008] As described above, EPA and / or DHA are unsaturated fatty acids contained in fish oils such as sardine oil, saury oil, herring oil, mackerel oil, and cod oil. For example, sardine oil contains about 16% EPA and DHA about 8.4%, and saury oil contains about 4.9% EPA and about 1% DHA.
0.5%, mackerel oil contains about 8.1% EPA and about 1% DHA
0.6%, cod oil about 13.3% EPA, DHA about 1
3.7% each.
【0009】本発明において用いるEPA及び/または
DHAもしくはこれを含有する油脂類は、魚油から常法
により分離、精製したものを利用しても良いが、単に魚
油を抽出することにより得られる、EPA及び/または
DHAを含有する油脂を利用しても良い。魚油を抽出す
る方法は特に限定されず、臨界ガス抽出法、分子蒸留
法、液体クロマトグラフ法等の油脂を抽出する方法とし
て公知の方法を採用することができる。The EPA and / or DHA or fats and oils containing DHA used in the present invention may be those separated and purified from fish oil by a conventional method, but may be obtained by simply extracting fish oil. And / or fats and oils containing DHA may be used. The method for extracting fish oil is not particularly limited, and a known method for extracting fats and oils such as a critical gas extraction method, a molecular distillation method, and a liquid chromatography method can be employed.
【0010】EPA及び/またはDHAを含有する油脂
は、そのまま本発明の化粧料に配合しても、また、更に
水蒸気蒸留、活性炭処理、酸性白土処理等によって精製
したものを利用しても良い。The fats and oils containing EPA and / or DHA may be used as they are in the cosmetics of the present invention, or may be further purified by steam distillation, activated carbon treatment, acid clay treatment and the like.
【0011】本発明の化粧料におけるEPA及び/また
はDHAの含有量は、0.0001〜10重量%(以下
単に「%」で示す)であり、より好ましくは0.01〜
5%である。 EPA及び/またはDHAの純度の低い
油脂を利用する場合は、EPA及び/またはDHAの含
有量として上記範囲内であれば良い。The content of EPA and / or DHA in the cosmetic of the present invention is 0.0001 to 10% by weight (hereinafter simply referred to as “%”), and more preferably 0.01 to 10% by weight.
5%. When using a fat or oil having a low purity of EPA and / or DHA, the content of EPA and / or DHA may be within the above range.
【0012】EPA及び/またはDHAの含有量が0.
0001%より少ないと十分な効果が得られないことが
あり、また、10%を越えて配合してもそれ以上の効果
の増大は見られず、かえって着色、臭いの発生や、剤型
によっては沈澱が生じる等、製品面での問題が生じる場
合がある。When the content of EPA and / or DHA is 0.5%
If it is less than 0001%, a sufficient effect may not be obtained, and even if it exceeds 10%, no further increase in the effect can be seen. Product problems such as precipitation may occur.
【0013】一方、本発明において他の必須成分である
センブリエキス、カンファ、ニコチン酸もしくはその誘
導体、ニンニクエキス、セファランチンおよびトウガラ
シチンキなどの成分(以下、「第二成分」と総称する)
は、いずれも、従来から化粧料に配合されている成分で
ある。On the other hand, components such as assembly extract, camphor, nicotinic acid or a derivative thereof, garlic extract, cepharanthin and chili tincture which are other essential components in the present invention (hereinafter collectively referred to as "second component")
Are all components conventionally blended in cosmetics.
【0014】これらの第二成分のうち、センブリエキ
ス、カンファ、ニンニクエキス、セファランチンおよび
トウガラシチンキは天然物中から抽出により得られる物
質であ、る。Among these second components, assembly extract, camphor, garlic extract, cepharanthin and pepper tincture are substances obtained by extraction from natural products.
【0015】すなわち、センブリエキスは、センブリ
[Swertia japonicaMakino
(Gentianaceae)]の開花期の全草からエ
タノール、精製水、またはこれらの混液で抽出して得ら
れるエキスであり、カンファは、クスノキ[Cinna
momum camphora Linne(Laur
aceae)]より得られるテルペンケトンである。な
お、カンファは、合成品としても得られる。 [0015] That is, the assembly extract is obtained from the assembly [Swertia japonica Makino].
(Gentianaceae)], which is obtained by extracting with ethanol, purified water, or a mixture thereof from the whole plant at the time of flowering, and camphor is a camphor tree [Cinna
mom camphora Line (Laur
aceae)]. What
In addition, camphor can be obtained as a synthetic product.
【0016】また、ニンニクエキスは、ニンニク(Alli
um scordoplasm L.またはAllium sativum L.)の鱗茎か
ら精製水、無水エタノール、プロピレングリコール、
1,3−ブチレングリコールまたはこれらの混液にて抽
出して得られるエキスである。The garlic extract is made of garlic (Alli
um scordoplasm L. or Allium sativum L.), purified water, absolute ethanol, propylene glycol,
It is an extract obtained by extraction with 1,3-butylene glycol or a mixture thereof.
【0017】更に、セファランチンは、ツヅラフジ科の
植物タマサキツヅラフジ(Stephaura cepharantha Haya
ta)の根より抽出して得られるものである。更にまた、
トウガラシチンキは、トウガラシ[Capsicum annuum Li
nne(Solanaceae)]またはその変種の果実をエタノー
ルで浸出して得られるチンキ剤である。なお、いずれの
場合も抽出方法、精製処理方法については特に制約はな
い。Further, cepharanthin is a plant belonging to the family Aphididae (Stephaura cepharantha Haya).
It is obtained by extracting from the root of ta). Furthermore,
Pepper tincture is a pepper [Capsicum annuum Li
nne (Solanaceae)] or a variant thereof is leached with ethanol. In any case, there is no particular limitation on the extraction method and the purification treatment method.
【0018】一方、ニコチン酸およびその誘導体は、ビ
タミンBの一種であり、牛肝臓または米糠等から抽出し
て得られるものでも合成によって得られるものでも良
く、ニコチン酸の他、ニコチン酸アミド、ニコチン酸D
L−α−トコフェロール、ニコチン酸メチル等のニコチ
ン酸誘導体が例示される。On the other hand, nicotinic acid and its derivatives are a kind of vitamin B and may be those obtained by extracting from beef liver or rice bran or the like, or those obtained by synthesis. In addition to nicotinic acid, nicotinamide, nicotinic acid amide and nicotine Acid D
Nicotinic acid derivatives such as L-α-tocopherol and methyl nicotinate are exemplified.
【0019】これら第二成分の本発明化粧料中の含有量
は、一般には0.0001〜5%、好ましくは0.001
〜3%である。これら成分の含有量が0.0001%よ
り少ない場合は、十分な効果が得られないことがあり、
また、5%を超えて配合しても効果がほぼ一定となり、
その増大は見られない。The content of these second components in the cosmetic of the present invention is generally 0.0001-5%, preferably 0.001.
~ 3%. If the content of these components is less than 0.0001%, sufficient effects may not be obtained,
Also, the effect is almost constant even if it exceeds 5%,
No increase is seen.
【0020】本発明の皮膚老化防止用化粧料は、常法に
従い、必須成分であるEPA及び/またはDHAもしく
はこれを含有する油脂類と、他の必須成分である第二成
分とを通常の化粧料として知られる種々の形態の基剤に
配合して調製することができる。The cosmetic composition for preventing skin aging according to the present invention comprises, according to a conventional method, EPA and / or DHA as essential components or oils and fats containing the same, and a second component as another essential component. It can be prepared by mixing with various types of bases known as additives.
【0021】化粧料の形態の例としては、特に限定され
ず、例えば、乳液、クリーム、化粧水、パック、分散
液、洗浄料等の化粧品とすることができ、化粧料の基剤
としては、これら化粧料の形態に応じた基剤、例えば、
精製水、低級アルコール類、多価アルコール類、油脂
類、界面活性剤、各種美容成分、紫外線吸収剤、増粘
剤、色素、防腐剤、香料等を用いることができる。Examples of the form of the cosmetic are not particularly limited, and may be, for example, cosmetics such as emulsions, creams, lotions, packs, dispersions, and detergents. Bases according to the form of these cosmetics, for example,
Purified water, lower alcohols, polyhydric alcohols, oils and fats, surfactants, various cosmetic ingredients, ultraviolet absorbers, thickeners, pigments, preservatives, fragrances, and the like can be used.
【0022】[0022]
【実施例】次に、実施例を挙げ本発明を更に詳しく説明
するが、本発明はこれらになんら制約されるものではな
い。Next, the present invention will be described in more detail with reference to examples, but the present invention is not limited to these examples.
【0023】実 施 例 1〜4 クリーム:下記表1に示す組成のクリームを製造し、肌
荒れ改善効果を調べた。この結果も表1に示す。なお、
クリームの製法および評価方法は次のとおりである。EXAMPLES 1-4 Creams: Creams having the compositions shown in Table 1 below were prepared, and the effects of improving skin roughness were examined. The results are also shown in Table 1. In addition,
The method for producing and evaluating the cream is as follows.
【0024】(製 法) A. 成分(8)、(10)〜(14)を加熱混合し、70℃に保
つ。 B. 成分(1)〜(7)および(9)を加熱混合し、70℃に保
つ。 C. 上記Bを先のAに加えて混合し、均一に乳化する。 D. 上記Cを冷却後、(15)を加え、均一に混合してクリ
ームを得た。(Production method) A. Components (8) and (10) to (14) are mixed by heating and maintained at 70 ° C. B. Components (1) to (7) and (9) are mixed by heating and kept at 70 ° C. C. Add the above B to the above A, mix and emulsify uniformly. D. After the above C was cooled, (15) was added and mixed uniformly to obtain a cream.
【0025】(評価方法)健常な男性135名をパネル
とし、1群15名として、顔面半面に実施例1〜4又は
比較例1〜5のクリームを、他の半面に比較例6のクリ
ームを、それぞれ1日1回、2週間塗布した。2週間
後、顔面皮膚レプリカを採取し、下記に示す基準により
評価した。得られた実施例1〜4、比較例1〜5のクリ
ーム塗布部位のレプリカのスコアから比較例6のクリー
ム塗布部位のレプリカのスコアを引いた値を肌荒れ改善
度とした。なお、パネルには、試験開始前のスコアが1
又は2の男性を選んだ。(Evaluation method) 135 healthy males were used as panels, and 15 males per group. The creams of Examples 1 to 4 or Comparative Examples 1 to 5 were applied to one half of the face, and the cream of Comparative Example 6 was applied to the other half. Was applied once a day for 2 weeks. Two weeks later, facial skin replicas were collected and evaluated according to the criteria shown below. The value obtained by subtracting the score of the replica of the cream-applied part of Comparative Example 6 from the obtained score of the replica of the cream-applied part of Examples 1-4 and Comparative Examples 1-5 was defined as the degree of skin roughness improvement. The score before the test was 1
Or I chose 2 men.
【0026】 肌状態スコア: [スコア] [ 状 態 ] 1 肌の皮溝が不鮮明であり、角質のはがれが認められる。 2 肌の皮溝がやや不鮮明であるかまたは一方向性が強い。 3 肌の皮溝は認められるが、浅いかまたは一方向性がやや強い。 4 肌の皮溝が認められるかまたはやや網目状である。 5 肌の皮溝がはっきり認められるかまたはきれいな網目状である。Skin Condition Score: [Score] [State] 1 Skin groove of skin is unclear and exfoliation of keratin is recognized. 2 Skin crevices are slightly unclear or strongly unidirectional. 3 Skin sulcus is recognized, but shallow or slightly unidirectional. 4 Skin sulcus is recognized or slightly reticulated. 5 Skin crevices are clearly recognized or have a fine mesh.
【0027】(結果)(Result)
【表1】 [Table 1]
【0028】以上の結果から、DHAと第二成分とを配
合した本発明化粧料は、DHAまたは第二成分を単独で
配合した場合に比べて、顕著な肌荒れ改善効果を奏する
ことが明らかである。From the above results, it is clear that the cosmetic of the present invention in which DHA and the second component are blended exhibits a remarkable skin roughness improving effect as compared with the case where DHA or the second component is blended alone. .
【0029】実 施 例 5〜6 クリーム:表2に示す組成および下記製法でクリームを
調製し、下記方法でその皮膚老化防止作用を調べた。EXAMPLES 5-6 Cream: A cream was prepared by the composition shown in Table 2 and by the following method, and its anti-aging effect was examined by the following method.
【0030】 * 栗田工業(株)製 ** トウガラシ中切のエチルアルコール浸出物 ***ニコチン酸アミド(有機合成薬品社製)[0030] * Kurita Water Industries Ltd. ** Ethyl alcohol leachate from pepper cuts *** Nicotinic acid amide (Synthetic Organic Chemicals)
【0031】(製 法) A. 成分(9)〜(11)および(13)を加熱混合し、70℃に
保つ。 B. 成分(1)〜(8)を加熱混合し、70℃に保つ。 C. 上記Bを先のAに加えて混合し、均一に乳化する。 D. 上記Cを冷却後、成分(12)を加え、均一に混合して
クリームを得た。(Production method) A. Components (9) to (11) and (13) are mixed by heating and maintained at 70 ° C. B. Components (1) to (8) are mixed by heating and kept at 70 ° C. C. Add the above B to the above A, mix and emulsify uniformly. D. After cooling the above C, the component (12) was added and mixed uniformly to obtain a cream.
【0032】(評価方法)26〜52歳の女性15名を
パネルとし、毎日朝と夜の2回、12週間にわたって洗
顔後に被験クリームの適量を顔面に塗布した。塗布によ
る美肌効果および皮膚老化防止効果を下記の基準によっ
て評価した。(Evaluation Method) Fifteen females aged 26 to 52 years were used as panels, and an appropriate amount of the test cream was applied to the face twice daily for 12 weeks, morning and night, after washing the face. The beautiful skin effect and the skin aging prevention effect of the application were evaluated according to the following criteria.
【0033】美肌効果: [評 価] [ 内 容 ] 有 効 肌のくすみが目立たなくなった。 やや有効 肌のくすみがやや目立たなくなった。 無 効 使用前と変化なし。Skin beautiful effect: [Evaluation] [Contents] Effective Skin dullness became inconspicuous. Slightly effective The dullness of the skin became slightly less noticeable. Ineffective No change from before use.
【0034】皮膚老化防止効果: [評 価] [ 内 容 ] 有 効 肌のはり、つやが改善された。 やや有効 肌のはり、つやがやや改善された。 無 効 使用前と変化なし。Anti-aging effect of skin: [Evaluation] [Contents] Effective Skin peeling and gloss were improved. Slightly effective Skin glue, gloss slightly improved. Ineffective No change from before use.
【0035】(結果)結果を表3に示す。(Results) The results are shown in Table 3.
【0036】 [0036]
【0037】表3の結果より明らかな如く、実施例5及
び6のクリームは肌の「つや」、「はり」の喪失・「く
すみ」等の発生の防止、改善に有効であり、皮膚老化防
止効果が認められた。As is evident from the results in Table 3, the creams of Examples 5 and 6 are effective in preventing and improving the occurrence of "glossy" and "bleeding" of the skin and the prevention of skin aging. The effect was recognized.
【0038】 実施例 7 化 粧 水 : <処方> (%) (1)ポリオキシエチレン硬化ヒマシ油(60E.0.) 1.0 (2)エチルアルコール 10.0 (3)防腐剤 0.1 (4)香料 適 量 (5)イワシ抽出油脂 1.0 (6)センブリエキス* 0.5 (7)ソルビトール(70%水溶液) 3.0 (8)ピロリドンカルボン酸ナトリウム 3.0 (9)精製水 残 量 *スエルチアニン[一丸ファルコス(株)製]Example 7 Cosmetic Water: <Formulation> (%) (1) Polyoxyethylene hydrogenated castor oil (60E.0.0) 1.0 (2) Ethyl alcohol 10.0 (3) Preservative 0.1 (4) Appropriate amount of fragrance (5) Sardine extracted oil and fat 1.0 (6) Assembly extract * 0.5 (7) Sorbitol (70% aqueous solution) 3.0 (8) Sodium pyrrolidonecarboxylate 3.0 (9) Purification water remaining amount * scan e Ruchianin [made Ichimaru Pharcos Co., Ltd.]
【0039】(製 法) A. 成分(1)〜(5)を加熱、混合溶解する。 B. 成分(6)〜(9)を加熱、混合溶解する。 C. 上記AとBを混合して均一とし、化粧水を得た。(Production Method) A. Components (1) to (5) are heated and mixed and dissolved. B. Heat and mix and dissolve components (6)-(9). C. The above A and B were mixed to make uniform, and a lotion was obtained.
【0040】実 施 例 8 乳液: <処方> (%) (1) ポリオキシエチレンソルビタ 1.0 ンモノステアレート(10E.O.) (2) ポリオキシエチレンソルビッ 0.5 トテトラオレエート(60E.O.) (3) グリセリンモノステアレート 1.0 (4) ステアリン酸 0.5 (5) ベヘニルアルコール 0.5 (6) 精製アボガド油 4.0 (7) トリ2−エチルヘキサン酸グ 4.0 リセリン (8) 防腐剤 0.1 (9) DHA* 1.0 (10)ウィッチヘーゼルエキス 0.1 (11)キサンタンガム(2%水溶液) 7.0 (12)1,3−ブチレングリコール 5.0 (13)カンファ** 1.0 (14)セファランチン*** 1.0 (15)精製水 残 量 (16)香料 適 量 * Serdary Research Lab.Inc.製 ** カンファ[高砂香料工業(株)製] ***セファランチン(丸善製薬社製)Example 8 Emulsion: <Formulation> (%) (1) Polyoxyethylene sorbita 1.0 monostearate (10E.O.) (2) Polyoxyethylene sorbita 0.5 Ethate (60E.O.) (3) Glycerin monostearate 1.0 (4) Stearic acid 0.5 (5) Behenyl alcohol 0.5 (6) Refined avocado oil 4.0 (7) Tri-2-ethylhexanoic acid G 4.0 Lyserin (8) Preservative 0.1 (9) DHA * 1.0 (10) Witch hazel extract 0.1 (11) Xanthan gum (2% aqueous solution) 7.0 (12) 1,3-butylene Glycol 5.0 (13) Campha ** 1.0 (14) Cepharanthin *** 1.0 (15) Residual water (16) Appropriate perfume * Serdary Research Lab. Inc. ** Campha [Takasago perfume Industrial Co., Ltd.] *** Sepharanthin (Maruzen Pharmaceutical Co., Ltd.)
【0041】( 製 法 ) A. 成分(10)〜(15)を加熱混合し、70℃に保つ。 B. 成分(1)〜(9)を加熱混合し、70℃に保つ。 C. 上記Bを先のAに加えて混合し、均一に乳化する。 D. 上記Cを冷却後、(16)を加え、均一に混合して乳液
を得た。(Preparation method) A. Components (10) to (15) are mixed by heating and maintained at 70 ° C. B. Components (1) to (9) are mixed by heating and kept at 70 ° C. C. Add the above B to the above A, mix and emulsify uniformly. D. After cooling the above C, (16) was added and mixed uniformly to obtain an emulsion.
【0042】実 施 例 9 軟 膏 : <処方> (%) (1) ステアリン酸 18.0 (2) セタノール 4.0 (3) トリエタノールアミン 2.0 (4) グリセリン 5.0 (5) サンマ抽出油脂 2.0 (6) ニンニクエキス* 1.0 (7) 精製水 残 量 * レイソーゲン[武山ガーリック化学(株)製]Example 9 Ointment: <Formulation> (%) (1) Stearic acid 18.0 (2) Cetanol 4.0 (3) Triethanolamine 2.0 (4) Glycerin 5.0 (5) Saury oil / fat 2.0 (6) Garlic extract * 1.0 (7) Remaining purified water * Reisogen [manufactured by Takeyama Garlic Chemical Co., Ltd.]
【0043】(製 法) A. 成分(3)、(4)及び(7)の一部を加熱混合
し、75℃に保つ。 B. 成分(1)、(2)および(5)を加熱混合し、7
5℃に保つ。 C. 上記Aを先のBに徐々に加える。 D. 上記Cを冷却しながら(7)の残部で溶解した
(6)を加え、軟膏を得た。(Production Method) A. A part of the components (3), (4) and (7) is mixed by heating and kept at 75 ° C. B. Components (1), (2) and (5) are mixed by heating.
Keep at 5 ° C. C. The above A is gradually added to the above B. D. While cooling C, (6) dissolved in the rest of (7) was added to obtain an ointment.
【0044】[0044]
【発明の効果】以上詳述した如く、本発明によりEPA
及び/またはDHAもしくはこれを含有する油脂類を配
合し、安定で優れた皮膚老化防止効果、肌荒れ改善効果
を有する化粧料が得られる。As described above, according to the present invention, EPA is used.
And / or DHA or fats and oils containing DHA is blended to obtain a cosmetic having a stable and excellent effect of preventing skin aging and improving skin roughness.
───────────────────────────────────────────────────── フロントページの続き (56)参考文献 特開 平2−48528(JP,A) 特開 昭62−138411(JP,A) 特開 昭62−87506(JP,A) 特開 昭47−43347(JP,A) 特開 昭63−174911(JP,A) 特開 昭60−209508(JP,A) (58)調査した分野(Int.Cl.7,DB名) A61K 7/00 - 7/50 ──────────────────────────────────────────────────続 き Continuation of the front page (56) References JP-A-2-48528 (JP, A) JP-A-62-138411 (JP, A) JP-A-62-87506 (JP, A) JP-A-47-1987 43347 (JP, A) JP-A-63-174911 (JP, A) JP-A-60-209508 (JP, A) (58) Fields investigated (Int. Cl. 7 , DB name) A61K 7/00-7 / 50
Claims (1)
サヘキサエン酸もしくはこれを含有する油脂類と、セン
ブリエキス、カンファ、ニコチン酸もしくはその誘導
体、ニンニクエキス、セファランチンおよびトウガラシ
チンキから選ばれる成分の一種または二種以上とを含有
する皮膚老化防止用化粧料。1. One or two or more components selected from eicosapentaenoic acid and / or docosahexaenoic acid or fats and oils containing the same and assembly extract, camphor, nicotinic acid or a derivative thereof, garlic extract, cepharanthin and pepper tincture. And a cosmetic for preventing skin aging.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10913792A JP3197938B2 (en) | 1992-04-03 | 1992-04-03 | Cosmetic for preventing skin aging |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10913792A JP3197938B2 (en) | 1992-04-03 | 1992-04-03 | Cosmetic for preventing skin aging |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH05286845A JPH05286845A (en) | 1993-11-02 |
| JP3197938B2 true JP3197938B2 (en) | 2001-08-13 |
Family
ID=14502535
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP10913792A Expired - Lifetime JP3197938B2 (en) | 1992-04-03 | 1992-04-03 | Cosmetic for preventing skin aging |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3197938B2 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ294130B6 (en) * | 1996-04-23 | 2004-10-13 | Theáprocterá@Ágambleácompany | Method of regulating mammalian skin pore size |
| GB9918023D0 (en) * | 1999-07-30 | 1999-09-29 | Unilever Plc | Skin care composition |
| JP2005529728A (en) * | 2002-06-18 | 2005-10-06 | マーテック・バイオサイエンシーズ・コーポレーション | Stable emulsion of oil in aqueous solution and process for its production |
| FR2850580A1 (en) * | 2003-02-04 | 2004-08-06 | Innadev Pharm | COMPOSITION BASED ON PLANTS AND OMEGA-3 POLYUNSATURATED FATTY ACIDS FOR THE PREVENTION AND TREATMENT OF WARTS, KERATOSES AND OTHER SKIN DISORDERS |
| WO2010119955A1 (en) * | 2009-04-17 | 2010-10-21 | ロート製薬株式会社 | Agent for preventing, inhibiting, or ameliorating skin aging due to buildup of advanced glycation end products |
| JP2010248148A (en) * | 2009-04-17 | 2010-11-04 | Rohto Pharmaceut Co Ltd | Breakdown agent of advanced glycation end product |
| US20200206173A1 (en) * | 2017-08-30 | 2020-07-02 | Conopco, Inc., D/B/A Unilever | A personal care composition |
-
1992
- 1992-04-03 JP JP10913792A patent/JP3197938B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPH05286845A (en) | 1993-11-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS59500129A (en) | Sebum-inhibiting cosmetic agent containing long-chain alkanol and antioxidant | |
| JPH0873324A (en) | Hair nourishment | |
| JP3197938B2 (en) | Cosmetic for preventing skin aging | |
| JPH09241146A (en) | Skin external agent | |
| JPH0253705A (en) | Cosmetic | |
| JP3170700B2 (en) | Cosmetic for preventing skin aging | |
| JPH0776513A (en) | Cosmetic for preventing skin aging | |
| JPH06336422A (en) | External skin preparation | |
| JPH09131393A (en) | Deodorant, deodorizing composition, and deodorizing cosmetic | |
| JP2001192328A (en) | Emulsified cosmetic | |
| JP2002284632A (en) | Superoxide anion scavenger containing sake lees as an active ingredient | |
| JPH05155738A (en) | Hair-tonic | |
| JP2021113172A (en) | Peptidyl arginine deiminase 1 expression promoter | |
| JPH04321615A (en) | Skin medicine for external use | |
| JP3231075B2 (en) | Cosmetic for preventing skin aging | |
| JP2003313113A (en) | Hair grower | |
| JP3197936B2 (en) | Cosmetics | |
| JP2000159653A (en) | Preparation for external use for skin | |
| JP3197937B2 (en) | Cosmetics | |
| JPH09175947A (en) | Hair growth agent composition | |
| JPWO1995019160A1 (en) | Blood flow improver and cosmetic | |
| JP2855274B2 (en) | Hair restoration | |
| JP3382148B2 (en) | External preparation for head | |
| JP2021066725A (en) | Topical skin preparation | |
| JP3367621B2 (en) | Cosmetic for wrinkle improvement |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120608 Year of fee payment: 11 |
|
| EXPY | Cancellation because of completion of term | ||
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120608 Year of fee payment: 11 |